Has Vivian Griffin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,784 in general payments to Vivian Griffin, MD across 324 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vivian Griffin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vivian Griffin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vivian Griffin, MD

Body Imaging · Trinity, FLNPI 1801898614

Payments from drug & device makers

$6,784in general payments, 2019–2025

Across 324 payments — averaging $20.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$1K
Merck$680
AbbVie$450
Johnson & Johnson$433
Daiichi Sankyo Inc.$399
AstraZeneca$312
plus $3K from 49 others

What the payments were for

Food & beverage$6,784100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	67	$1,174
Merck	32	$680
AbbVie	22	$450
Johnson & Johnson(3 entities)	23	$433
Daiichi Sankyo Inc.	16	$399
AstraZeneca(2 entities)	11	$312
Sanofi	14	$267
Regeneron Healthcare Solutions, Inc.	9	$261
Takeda Pharmaceuticals U.S.A., Inc.	6	$183
Gilead	8	$171
Seagen Inc.	10	$161
Incyte Corporation	8	$137
Astellas Pharma Global Development	1	$125
Myriad Genetic Laboratories, Inc.	2	$116
Intuitive Surgical	1	$109
Pharmacyclics LLC, An Abbvie Company	5	$101
Jazz Pharmaceuticals Inc.	5	$94
Octapharma USA, Inc.	1	$90
Taiho Oncology, Inc.	5	$90
CSL Behring	5	$83
Bayer	5	$78
Amgen(2 entities)	5	$75
Puma Biotechnology, Inc.	4	$67
Dendreon Pharmaceuticals LLC	2	$64
Eisai Inc.	3	$62
Rigel Pharmaceuticals, Inc.	2	$59
Astellas Pharma US Inc	3	$59
EMD Serono, Inc.	4	$58
Kyowa Kirin, Inc.	2	$56
Array Biopharma Inc	3	$55
E.r. Squibb & Sons, L.L.C.	3	$53
Pharmacosmos Therapeutics Inc.	2	$50
Blueprint Medicines Corporation	3	$46
Geron Corporation	2	$46
Pfizer	2	$44
Myovant Sciences Inc.	3	$43
GSK	2	$39
GT Medical Technologies, Inc	1	$35
Karyopharm Therapeutics Inc.	2	$33
Sobi, Inc	2	$32
Ipsen Biopharmaceuticals, Inc	2	$31
GE HealthCare	2	$30
Stemline Therapeutics Inc.	1	$29
Aurobindo Pharma USA, Inc.	2	$26
Syndax Pharmaceuticals, Inc.	1	$25
Tersera Therapeutics LLC	1	$22
Pharmaessentia USA Corporation	1	$20
AVEO Pharmaceuticals, Inc.	1	$18
Beigene USA, Inc.	1	$17
Mirati Therapeutics, Inc.	1	$14
Lilly USA, LLC	1	$14
Epizyme, Inc.	1	$14
Acceleron Pharma, Inc.	1	$13
Genentech USA, Inc.	1	$12
Dova Pharmaceuticals	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few body imaging providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$2,831,499

Medicare patients

190

Services billed

17,109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	27	$1,373
Ondansetron OdtOndansetron	17	$516
Clotrimazole	12	$377
Lidocaine Hcl ViscousLidocaine Hcl	21	$355
Dexamethasone	18	$271
Tamsulosin Hcl	15	$63

Paid to pharmacies, not to this prescriber.

Other body imaging in Trinity

Marco AmendolaMiami$56K
Joel FishmanMiami$2K
Surya ChundruMiami$1K
Sean Maldonado RamirezJacksonville$739
Steven KaridasWeston$424
Omar ShwaikiTampa$165
William LindseyTallahassee$159
Luciano MastrogiovanniMiami$108
Pamela DicksonMiami$51
Elaine KondroskiMelbourne$34

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →